CRBP · Corbus Pharmaceuticals Holdings, Inc. · Executive Compensation
$6.05
+0.20 (+3.42%)
At close · Oct 6
Return incl. dividend (before tax)
Market Cap
$130.36M
Shares
19.34M
Volume · Oct 5
793.49K
Avg daily vol (3M)
717.83K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Yuval Cohen | Chief Executive Officer | $3,750,125 |
| Dominic Smethurst | Chief Medical Officer | $1,800,142 |
| Sean Moran | Chief Financial Officer | $1,789,423 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Yuval Cohen | Chief Executive Officer | $4,245,438 |
| Dominic Smethurst | Chief Medical Officer | $2,892,972 |
| Sean Moran | Chief Financial Officer | $2,429,505 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Yuval Cohen | Chief Executive Officer | $1,137,622 |
| Rachael Brake | Chief Scientific Officer | $839,867 |
| Sean Moran | Chief Financial Officer | $717,256 |
| Dominic Smethurst | Chief Medical Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Yuval Cohen | Chief Executive Officer | $1,442,841 |
| Sean Moran | Chief Financial Officer | $778,616 |
| Rachael Brake | Chief Scientific Officer | $763,795 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Yuval Cohen | Chief Executive Officer | $4,858,306 |
| Sean Moran | Chief Financial Officer | $1,844,917 |
| Rachael Brake | Chief Scientific Officer | $15,807 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Nishant Saxena | Chief Business Officer | Appointed | 2026-05-21 |
| Nishant Saxena | Chief Business Officer | Appointed | 2026-05-21 |
| Brent Pfeiffenberger | member of the Board | Appointed | 2026-05-14 |
| Dominic Smethurst | Chief Medical Officer | Resigned | 2026-04-07 |
| Alan Holmer | Board of Directors | Retired | 2025-12-18 |
| Ian Hodgson | Chief Operating Officer | Appointed | 2025-03-18 |
| Avery W. Catlin | member of the Board’s Audit Committee and Compensation Committee | Resigned | 2024-08-20 |
| Winston W. Kung | member of the Board | Appointed | 2024-08-20 |
| Avery W. Catlin | member of the Board of Directors | Resigned | 2024-08-20 |
| Yong Ben | director | Appointed | 2024-05-20 |
| Anne Altmeyer | director | Appointed | 2024-05-20 |
| John Jenkins | director | Appointed | 2024-05-20 |
| Peter Salzmann | director | Appointed | 2024-05-20 |
| Rachelle Jacques | director | Appointed | 2024-05-20 |
| Avery W. Catlin | director | Appointed | 2024-05-20 |
| Alan Holmer | director | Appointed | 2024-05-20 |
| Yuval Cohen | director | Appointed | 2024-05-20 |
| Rachael Brake, Ph.D. | Chief Scientific Officer | Resigned | 2024-02-06 |
| Yong Ben | Board of Directors | Appointed | 2023-03-07 |
| Craig Millian | Chief Operating Officer | Resigned | 2023-03-07 |
| Yong Ben, M.D., MBA | member of the Board | Appointed | 2023-03-06 |
| Anne Altmeyer, Ph.D., MBA, MPH | member of the Board | Appointed | 2022-09-26 |